Anomalous NMR Magnetic Shifts in CeCoIn_5

We report ^{115}In and ^{59}Co Nuclear Magnetic Resonance (NMR) measurements in the heavy fermion superconductor CeCoIn_5 above and below T_c. The hyperfine couplings of the In and Co are anisotropic and exhibit dramatic changes below 50K due to changes in the crystal field level populations of the Ce ions. Below T_c the spin susceptibility is suppressed, indicating singlet pairing.Comment: 4 pages, 4 figure

Radon Exhalation Rates of Some Granites Used in Serbia

In order to address concern about radon exhalation in building material, radon exhalation rate was determined for different granites available on Serbian market. Radon exhalation rate, along with mass exhalation rate and effective radium content were determined by closed chamber method and active continuous radon measurement technique. For this research, special chambers were made and tested for back diffusion and leakage, and the radon concentrations measured were included in the calculation of radon exhalation. The radon exhalation rate ranged from 0.161 Bq/m(2)h to 0.576 Bq/m(2)h, the mass exhalation rate from 0.167 Bq/kgh to 0.678 Bq/kgh, while the effective radium content was found to be from 12.37 Bq/kg to 50.23 Bq/kg. The results indicate that the granites used in Serbia have a low level of radon exhalation

A Method of Approximate Greens Function for Solving Reflection of Particles in Plane Geometry

A method for approximate analytical solution of transport equation for particles in plane geometry is developed by solving Fredholm integral equations. Kernels of these equations are the Greens functions for infinite media treated approximately. Analytical approximation of Greens function is based on decomposition of the functions into terms that are exactly analytically solved and those which are approximately obtained by usual low order DPN approximation. Transport of particles in half-space is treated, and reflection coefficient is determined in the form of an analytical function. Comparison with the exact numerical solution and other approximate methods justified the proposed analytical technique

Photon Scattering and Reflection in Medical Diagnostic Energy Domain

The dependence of reflected photons angular and energy distributions on parameter c - the probability for large-angle scattering - is treated in this paper. The simulation of photon reflection was performed by the FOTELP code for a normal incidence of photons into infinite slabs of common shielding materials, and for the photon initial energies of 20 keV up to 100 keV

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

BACKGROUND Clostridium difficile is the most common cause of infectious diarrhea in hospitalized patients. Recurrences are common after antibiotic therapy. Actoxumab and bezlotoxumab are human monoclonal antibodies against C. difficile toxins A and B, respectively. METHODS We conducted two double-blind, randomized, placebo-controlled, phase 3 trials, MODIFY I and MODIFY II, involving 2655 adults receiving oral standard-of-care antibiotics for primary or recurrent C. difficile infection. Participants received an infusion of bezlotoxumab (10 mg per kilogram of body weight), actoxumab plus bezlotoxumab (10 mg per kilogram each), or placebo; actoxumab alone (10 mg per kilogram) was given in MODIFY I but discontinued after a planned interim analysis. The primary end point was recurrent infection (new episode after initial clinical cure) within 12 weeks after infusion in the modified intention-to-treat population. RESULTS In both trials, the rate of recurrent C. difficile infection was significantly lower with bezlotoxumab alone than with placebo (MODIFY I: 17% [67 of 386] vs. 28% [109 of 395]; adjusted difference, −10.1 percentage points; 95% confidence interval [CI], −15.9 to −4.3; P<0.001; MODIFY II: 16% [62 of 395] vs. 26% [97 of 378]; adjusted difference, −9.9 percentage points; 95% CI, −15.5 to −4.3; P<0.001) and was significantly lower with actoxumab plus bezlotoxumab than with placebo (MODIFY I: 16% [61 of 383] vs. 28% [109 of 395]; adjusted difference, −11.6 percentage points; 95% CI, −17.4 to −5.9; P<0.001; MODIFY II: 15% [58 of 390] vs. 26% [97 of 378]; adjusted difference, −10.7 percentage points; 95% CI, −16.4 to −5.1; P<0.001). In prespecified subgroup analyses (combined data set), rates of recurrent infection were lower in both groups that received bezlotoxumab than in the placebo group in subpopulations at high risk for recurrent infection or for an adverse outcome. The rates of initial clinical cure were 80% with bezlotoxumab alone, 73% with actoxumab plus bezlotoxumab, and 80% with placebo; the rates of sustained cure (initial clinical cure without recurrent infection in 12 weeks) were 64%, 58%, and 54%, respectively. The rates of adverse events were similar among these groups; the most common events were diarrhea and nausea. CONCLUSIONS Among participants receiving antibiotic treatment for primary or recurrent C. difficile infection, bezlotoxumab was associated with a substantially lower rate of recurrent infection than placebo and had a safety profile similar to that of placebo. The addition of actoxumab did not improve efficacy. (Funded by Merck; MODIFY I and MODIFY II ClinicalTrials.gov numbers, NCT01241552 and NCT01513239.

The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey

It is unclear to what extent the COVID-19 pandemic has influenced the use of remote monitoring (RM) of cardiac implantable electronic devices (CIEDs). The present physician-based European Heart Rhythm Association (EHRA) survey aimed to assess the influence of the COVID-19 pandemic on RM of CIEDs among EHRA members and how it changed the current practice. The survey comprised 27 questions focusing on RM use before and during the pandemic. Questions focused on the impact of COVID-19 on the frequency of in-office visits, data filtering, reasons for initiating in-person visits, underutilization of RM during COVID-19, and RM reimbursement. A total of 160 participants from 28 countries completed the survey. Compared to the pre-pandemic period, there was a significant increase in the use of RM in patients with pacemakers (PMs) and implantable loop recorders (ILRs) during the COVID-19 pandemic (PM 24.2 vs. 39.9%, P = 0.002; ILRs 61.5 vs. 73.5%, P = 0.028), while there was a trend towards higher utilization of RM for cardiac resynchronization therapy-pacemaker (CRT-P) devices during the pandemic (44.5 vs. 55%, P = 0.063). The use of RM with implantable cardioverter-defibrillators (ICDs) and CRT-defibrillator (CRT-D) did not significantly change during the pandemic (ICD 65.2 vs. 69.6%, P = 0.408; CRT-D 65.2 vs. 68.8%, P = 0.513). The frequency of in-office visits was significantly lower during the pandemic (P < 0.001). Nearly two-thirds of participants (57 out of 87 respondents), established new RM connections for CIEDs implanted before the pandemic with 33.3% (n = 29) delivering RM transmitters to the patient's home address, and the remaining 32.1% (n = 28) activating RM connections during an in-office visit. The results of this survey suggest that the crisis caused by COVID-19 has led to a significant increase in the use of RM of CIEDs

Revealing non-equilibrium dynamics by holography: The case of Briggs- Rauscher reaction

editorial reviewe

Revealing Self organization of Granular Matter: From Fundamental Physics to Military Technology Applications

editorial reviewe

Revealing the Impact of Different Shapes of Light on the Briggs- Rauscher Oscillatory Dynamics

editorial reviewe